Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats
about
sameAs
Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pupsNew insights in bilirubin metabolism and their clinical implicationsShort-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in Young Long-Evans ratsPatterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in ratsTemporal expression profiles of organic anion transport proteins in placenta and fetal liver of the ratDevelopment and characterization of a recombinant Madin-Darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1)Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.The mechanism of enterohepatic circulation in the formation of gallstone disease.Functional interactions between P-glycoprotein and CYP3A in drug metabolism.Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.Xenobiotic transporter expression along the male genital tract.Regulation of drug and bile salt transporters in liver and intestine.Role of nuclear receptor CAR in carbon tetrachloride-induced hepatotoxicityRegulation of hepatic ABCC transporters by xenobiotics and in disease states.The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitisMolecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitisMolecular and cellular physiology of renal organic cation and anion transport.Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters.Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions.Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition.Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice.RNA Sequencing Quantification of Xenobiotic-Processing Genes in Various Sections of the Intestine in Comparison to the Liver of Male Mice.The Nrf2 activator oltipraz also activates the constitutive androstane receptor.Evaluation of Antioxidant, Immunomodulatory Activities, and Safety of Ethanol Extract and Fractions of Gongronema latifolium Fruit.Genetic and biochemical study of dual hereditary jaundice: Dubin-Johnson and Gilbert's syndromes. Haplotyping and founder effect of deletion in ABCC2LOSS of Mrp1 alters detoxification enzyme expression in a tissue- and hormonal-status-specific manner.Effects of drug transporters on volume of distribution.Nuclear receptors as therapeutic targets in cholestatic liver diseases.CFTR is the primary known apical glutathione transporter involved in cigarette smoke-induced adaptive responses in the lungSignaling control of the constitutive androstane receptor (CAR)Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer.Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics.The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs.New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition.The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways.CFTR directly mediates nucleotide-regulated glutathione flux.Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3.Expression of multidrug resistance-associated protein 2 in human gallbladder carcinoma.Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein.
P2860
Q24655695-0203570C-FDF8-4365-ABDE-55643E4ADBF2Q26863145-06B87FB0-995B-4F02-A40F-42DD93625597Q28396967-291751D5-0AFD-4CA9-AAD0-88F721358C82Q28564505-23D8014E-8CC6-4D3D-BC26-0D11D77CEB96Q28568887-91D704C3-C476-4CFD-BC6C-25E8D698CF8EQ28582391-2DDA1D9E-F5DF-4954-BFDD-225013E33564Q33714593-21528FCF-CF09-4FBB-BEFE-512421456BF1Q34349336-B82323F3-06C7-453F-BC27-B296671CF692Q34396525-070F666A-101C-4951-AA4B-09D7CB144546Q34550483-FD28964C-3238-4187-9C62-5CBBD8F897EBQ34568808-99947FB0-B26D-4088-8CB3-E031AD3D51AFQ35359647-F7046EE9-D902-4EAB-9F2B-46A217DB548EQ35620646-A46A287C-132E-486B-9E81-C81978884C5BQ35621605-B8289CAB-65C7-4A00-9305-5CC1206AE7C1Q35690177-36096901-5E48-4CC9-A5AD-62088927BC10Q35761434-EA93A341-1EEC-4C13-A739-2AFBA6247241Q35776660-002CEAB8-3230-4249-9848-CD3956388FF7Q35842999-32FAB59A-354E-40B3-96CA-87C49BDB6332Q35956173-F76537AE-74D6-4E95-A9D7-5A255584A37AQ36300799-1607FAD7-089F-4128-89FB-9FE5D8DF6814Q36544905-429EC319-6B9B-4239-8028-9C6727161DD8Q36808566-C806E27F-9744-4D03-AF1A-F5E2A859FECFQ36947714-2A8EC162-AF3E-47E7-9D97-0E5078BC14C8Q36957687-52A3ABAC-134E-4BEB-A750-E929D8D521CDQ36979526-499F49D0-32DD-4623-BCEE-58D522E1A20EQ37058526-CCEE46EE-34C0-4A25-88C9-96ED497D378CQ37058949-3E74B041-12EF-4B08-8C51-DB01726AEBD9Q37214523-E0AAD376-C9B0-4A8A-A11A-F0D728A5FAF7Q37230857-4F5B0948-871E-4836-A122-07175DC63006Q37576905-8F7EC816-E65D-4770-A983-40545E5450F6Q37642162-DBBCF43D-9046-4A94-9D3C-E5C034408791Q37740126-A6B1EE29-CD79-427F-81B7-4F29336BF85FQ37969214-DDA15413-00FC-4F68-8E3B-44996F5BEF9BQ38071690-CAB28F83-9AEA-4D03-B65E-D01DC151EF48Q38266172-6CF31410-DCC0-43E7-8766-DF7BBC38B17CQ38603051-DF169187-9A2A-40D3-90CB-E0174939D273Q39756358-A8887580-7A67-4A9B-8AF8-72BBC9FBD90CQ40696242-7DBBDCAD-19D4-467C-AD68-777F6E5DC1CCQ41444935-9E9CBF0A-E86C-4A0C-8ED5-08495457C64DQ44210260-8A58F548-9308-4AD7-B626-F994F8D43CDA
P2860
Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Organ distribution of multidru ...... ne receptor activators in rats
@ast
Organ distribution of multidru ...... ne receptor activators in rats
@en
Organ distribution of multidru ...... ne receptor activators in rats
@nl
type
label
Organ distribution of multidru ...... ne receptor activators in rats
@ast
Organ distribution of multidru ...... ne receptor activators in rats
@en
Organ distribution of multidru ...... ne receptor activators in rats
@nl
prefLabel
Organ distribution of multidru ...... ne receptor activators in rats
@ast
Organ distribution of multidru ...... ne receptor activators in rats
@en
Organ distribution of multidru ...... ne receptor activators in rats
@nl
P2093
P356
P1476
Organ distribution of multidru ...... ne receptor activators in rats
@en
P2093
Curtis D Klaassen
David R Johnson
Dylan P Hartley
Nathan J Cherrington
P304
P356
10.1124/JPET.300.1.97
P407
P577
2002-01-01T00:00:00Z